The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

Stocks in the health-care industry rose as markets grew more confident that U.S. borrowing costs will fall, while companies in the sector pleased investors in their quarterly reports. Gilead Sciences ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

HHS Secretary Kennedy’s decision is based on a fundamental misunderstanding of vaccinology that could cost lives in future pandemics.

GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...

Pima County health officials say fall vaccine supplies remain steady despite changes in federal research funding.

Many health officials predict HHS Secretary Robert F. Kennedy Jr's action could hurt the country’s ability to respond quickly to the next pandemic.

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...